CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia

被引：0

作者：

Jinghua Wang

Siyu Chen

Wei Xiao

Wende Li

Liang Wang

Shuo Yang

Weida Wang

Liping Xu

Shuangye Liao

Wenjian Liu

Yang Wang

Nawei Liu

Jianeng Zhang

Xiaojun Xia

Tiebang Kang

Gong Chen

Xiuyu Cai

Han Yang

Xing Zhang

Yue Lu

Penghui Zhou

机构：

[1] State Key Laboratory of Oncology in Southern China,Department of Hematological Oncology

[2] Collaborative Innovation Center for Cancer Medicine,Department of Hematology

[3] Sun Yat-Sen University Cancer Center,Department of Hematology

[4] Guangdong Laboratory Animals Monitoring Institute,Department of Experimental Research

[5] Guangdong Key Laboratory of Laboratory Animals,undefined

[6] Zhujiang Hospital of Southern Medical University,undefined

[7] Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,undefined

[8] Sun Yat-Sen University Cancer Center,undefined

来源：

Journal of Hematology & Oncology | / 11卷

关键词：

Acute myeloid leukemia; C-type lectin-like molecule-1; Chimeric antigen receptor; Immunotherapy; Leukemia stem cells;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] New target of interest for developing CAR-T in acute myeloid leukemia?
Helene, Gardeney
Maria-Pilar, Gallego-Hernanz
HEMATOLOGIE, 2022, 28 (01): : 13 - 15
[32] CLL-1-Targeted Allogeneic CAR-T Cells Exhibit High on- Target Specificity and Potent Cytotoxicity in Preclinical Models of Acute Myeloid Leukemia
Francica, Brian
Garner, Elizabeth
Namburi, Sai
Colgan, Cian
Fowler, Tristan
Mutha, Devin
Aviles, Art
Stanaway, Morena
Guo, Raymond
An, Zili
Kelly, Erin
Degagne, Emilie
Kwong, George
Edwards, Leslie
Jakes, Emma
Shaw, McKay
Schilling, Benjamin
Huynh, Jeremy
Luu, Ricky
Sidorov, Max
Mousali, Rhonda
Otsmaa, Mikk
Lauer, Peter
Skoble, Justin
Kanner, Steven
BLOOD, 2023, 142
[33] Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia
Zhang, Rui
Zhao, Yifan
Chai, Xiao
Wang, Yingshuai
Zhao, Mohan
Guo, Shujing
Zhang, Yu
Zhao, Mingfeng
TRANSLATIONAL ONCOLOGY, 2025, 52
[34] The efficacy and safety of anti-CLL1 based CAR-T cells in children with relapsed or refractory acute myeloid leukemia: A multicenter interim analysis.
Zhang, Hui
Bu, Chaoke
Peng, Zhiyong
Luo, Min
Li, Chunfu
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[35] Intracellular retention of TCRαβ/CD3 to generate novel allogeneic CAR-T cells targeting CLL1 for treating acute myelocytic leukemia
Li, Jun
Liu, Kaichun
Xu, Guanggui
Chen, Shanshan
Zhang, Yinhang
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[36] C-type like lectin molecule 1 (CLL-1)-specific chimeric antigen receptor (CAR) T cell therapy for the treatment of acute myeloid leukemia (AML)
Schanda, N.
Sedloev, D.
Schmitt, A.
Mueller-Tidow, C.
Schmitt, M.
Sauer, T.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 87 - 88
[37] Phase I Clinical Trial of Autologous CLL1 CAR-T Therapy for Pediatric Patients with Relapsed and Refractory Acute Myeloid Leukemia
Bu, Chaoke
Peng, Zhiyong
Luo, Min
Li, Guangchao
Li, Chunfu
BLOOD, 2020, 136
[38] CAR-T cells for childhood and adult Acute Lymphoblastic Leukemia
Dourthe, Marie Emilie
Baruchel, Andre
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (07): : 1441 - 1451
[39] Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemiass
Xu, Jianmei
Zhang, Huan
Zhao, Yifan
Zhang, Xiaomei
Guo, Shujing
Shi, Xiaoxue
Xiao, Xia
Lyu, Hairong
Zhang, Yu
He, Xiaoyuan
Zhao, Mingfeng
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (05)
[40] Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
Shujing Guo
Xuejin Gao
Mahara Sadhana
Ruiting Guo
Jile Liu
Wenyi Lu
Ming Feng Zhao
Current Treatment Options in Oncology, 2023, 24 : 1614 - 1632

← 1 2 3 4 5 →